
Onyx is developing a virtual immune system to accelerate the creation of precision medicines. They achieve this by conducting research studies that thoroughly profile autoimmune diseases, integrating multi-omics data with patient health records. Onyx's business model involves members contributing health data and samples for scientific study. In return, members share in the revenue generated from their data and receive additional membership benefits. This approach ensures data equity and leverages AI for biological modeling.

Onyx is developing a virtual immune system to accelerate the creation of precision medicines. They achieve this by conducting research studies that thoroughly profile autoimmune diseases, integrating multi-omics data with patient health records. Onyx's business model involves members contributing health data and samples for scientific study. In return, members share in the revenue generated from their data and receive additional membership benefits. This approach ensures data equity and leverages AI for biological modeling.